Medivir AB (Sweden) Today
| MVIR Stock | 2.88 0.17 6.27% |
Performance0 of 100
|
Medivir AB is selling for under 2.88 as of the 25th of November 2024; that is 6.27 percent increase since the beginning of the trading day. The stock's last reported lowest price was 2.75. Medivir AB has hardly any chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. Equity ratings for Medivir AB are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 6th of December 2022 and ending today, the 25th of November 2024. Click here to learn more.
Medivir AB Risk Profiles
Although Medivir AB's alpha and beta are two of the key measurements used to evaluate Medivir AB's performance over the market, the standard measures of volatility play an important role as well.
Medivir Stock Against Markets
Medivir AB Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Medivir AB stock to make a market-neutral strategy. Peer analysis of Medivir AB could also be used in its relative valuation, which is a method of valuing Medivir AB by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Additional Tools for Medivir Stock Analysis
When running Medivir AB's price analysis, check to measure Medivir AB's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Medivir AB is operating at the current time. Most of Medivir AB's value examination focuses on studying past and present price action to predict the probability of Medivir AB's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Medivir AB's price. Additionally, you may evaluate how the addition of Medivir AB to your portfolios can decrease your overall portfolio volatility.